Iterum Therapeutics Plc (ITRM) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts ITRM Hot Sheet
Join SI Premium – FREE
Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q2 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verizon to cut 3,000 jobs as it shifts stores to franchises
- IPG Photonics to acquire Lumibird Medical for up to €350M
- Wipro (WIT) Misses Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
